Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,208 papers from all fields of science
Search
Sign In
Create Free Account
penthienate
Known as:
2-((cyclopentylhydroxy-2-thienylacetyl)oxy)-N,N-diethyl-N-methylethanaminium
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Ammonium Compounds
Quaternary Ammonium Compounds
Poisoning by parasympatholytics (anticholinergics and antimuscarinics) and spasmolytics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Anticholinergic medication for the unstable bladder: Prospective trials of imipramine/propantheline versus penthienate and oxybutynin versus penthienate
B. Clarke
International Urogynecology Journal
2005
Corpus ID: 21827627
A comparison was made of three drug regimens: imipramine (Tofranil)/propantheline, oxybutynin (Ditropan) and penthienate bromide…
Expand
1997
1997
Anticholinergic Medication for the Unstable Bladder: Prospective Trials of Imipramine/Propantheline Versus Penthienate and Oxybutinin Versus Penthienate
J. Clarke
1997
Corpus ID: 70601013
1996
1996
Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline
G. Coombes
,
R. Millard
Medical Journal of Australia
1996
Corpus ID: 26468037
To compare the efficacy of penthienate with that of propantheline and placebo for treatment of primary idiopathic detrusor…
Expand
1957
1957
A note on the intestinal absorption of penthienate (monodral).
Levine Rm
,
Clark Bb
1957
Corpus ID: 99581518
1957
1957
A note on the intestinal absorption of penthienate (monodral).
R. M. Levine
,
B. B. Clark
Archives internationales de pharmacodynamie et de…
1957
Corpus ID: 2061752
1957
1957
Penthienate as a Mydriatic
W. Johnson
1957
Corpus ID: 81196641
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE